May 24, 2011 - Hologic Inc. announced the first nine U.S. cities for a series of evening events to introduce clinicians to the Selenia Dimensions 2-D/3-D breast tomosynthesis system and gain hands-on experience with this new technology.
The Hologic system is the first commercial mammography system with breast tomosynthesis technology for breast cancer screening and diagnosis. The Selenia Dimensions system gives radiologists the option of offering their patients a 3-D tomosynthesis exam in addition to the conventional 2-D exam – all in one compression, in just seconds. In clinical studies Hologic submitted to the U.S. Food and Drug Administration (FDA), radiologists reading 2-D mammography plus 3-D breast tomosynthesis images compared to 2-D images alone demonstrated superior clinical performance in specificity, the confidence to rule out breast cancer without recalling the patient for further study, and also demonstrated improved sensitivity, the proportion of mammograms which include breast cancers that were correctly diagnosed.
Experts specializing in the areas of clinical image science, connectivity, medical education and managed care will participate in the Hologic events. The first leg of the U.S. tour will include the following cities:
- May 24th, Boston, Mass.
- June 14th, New York, N.Y.
- June 16th, Chicago, Ill
- July 12th, Seattle, Wash.
- July 14th, San Francisco, Calif.
- July 19th, Denver, Colo.
- July 21st, Dallas, Texas
- July 26th, Atlanta, Ga.
- July 28th, Tampa, Fla.
Radiologists, administrators, technologists, and other interested parties may register for the no-cost, first-of-its-kind events at www.hologic.com/tomoshows.
For more information: www.hologic.com
July 29, 2024 
